NEWS









The new consensus-based recommendations from EAS and EFLM are now available.

The new consensus-based recommendations from EAS and EFLM are now available.

Based on the 2019 ESC/EAS Guidelines for the management of dyslipidaemias, the new consensus-based recommendations from EAS and EFLM are now available. The 2019 ESC/EAS Guidelines recommend the Lp(a) analysis for the population over 40-years-old, in order to identify individuals with a high risk to develop atherosclerotic cardiovascular disease. Clinicians claim that a one-off measurement […]

READ MORE "The new consensus-based recommendations from EAS and EFLM are now available."




Our CTO NAT Maurizio Gramegna is one of the Corporate Members of the IFCC Task Force on COVID-19

Our CTO NAT Maurizio Gramegna is one of the Corporate Members of the IFCC Task Force on COVID-19

  The International Federation of Clinical Chemistry and Laboratory Medicine IFCC has established a Task Force on COVID-19, in order to face the Public Health Emergency. Our CTO NAT Maurizio Gramegna has been selected by IFCC to be one of the Corporate Members of the Task Force on COVID-19, thanks to his long-lasting experience in […]

READ MORE "Our CTO NAT Maurizio Gramegna is one of the Corporate Members of the IFCC Task Force on COVID-19"




Our FOB Gold® system is the perfect partner for an efficient screening program

Our FOB Gold® system is the perfect partner for an efficient screening program

As every year, the Dutch RIVM publishes the report “Monitoring and Evaluation of the Colorectal Cancer Screening Programme”, regarding the CRC Screening Program in the Netherlands, with which the Institute proudly underlines the successful results obtained. This outcome, regards all aspects of the procedure, from the enrollment of citizens, to the intake of samples, to […]

READ MORE "Our FOB Gold® system is the perfect partner for an efficient screening program"








Our ready-to-use Real-Time PCR mix for the detection of novel coronavirus disease is ready

Our ready-to-use Real-Time PCR mix for the detection of novel coronavirus disease is ready

Our ready-to-use lyo Real-Time PCR mix for the detection of novel coronavirus disease is ready. We have developed two kits: COVID-19 HK, that follows the Hong Kong protocol and COVID-19 B, based on Berlin protocol. These two kits will assure you the highest sensitivity and specificity. More info available here!    

READ MORE "Our ready-to-use Real-Time PCR mix for the detection of novel coronavirus disease is ready"








NeuMoDx™ Molecular and Sentinel Diagnostics form a partnership to develop multiple new assays for the NeuMoDx™ 96 and 288 Molecular Systems.

NeuMoDx™ Molecular and Sentinel Diagnostics form a partnership to develop multiple new assays for the NeuMoDx™ 96 and 288 Molecular Systems.

Ann Arbor, MI USA and Milan, Italy (December 9, 2019) – NeuMoDx™ Molecular, a sample-to-result molecular diagnostic company focused on developing testing solutions for hospital and commercial reference laboratory customers, and Sentinel Diagnostics, a leading company engaged in the development and production of diagnostic kits for Clinical Chemistry, Immunochemistry and Molecular Biology, announced today their […]

READ MORE "NeuMoDx™ Molecular and Sentinel Diagnostics form a partnership to develop multiple new assays for the NeuMoDx™ 96 and 288 Molecular Systems."